va semaglutide criteria for use Once-Weekly Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (PAUSE) | Diabetes Therapy Maximizing Semaglutide: Understanding the Doses

Clinical trials of GLP-1 receptor agonists consistently show that a sizable portion of weight loss often comes from lean mass

High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation

Months 612: Long-Term Progress and Maintenance Many patients continue losing weight throughout the second half of the first year, although the rate of weight loss often slows compared with the earlier months

Most clients notice smoother skin and a refreshed feeling after the first session

The weight loss from GLP-1 treatment increases self-confidence, improves mood, and decreases anxiety and depression symptoms